{
  "ticker": "GSS",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971293",
  "id": "02971293",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250722",
  "time": "0838",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250722/pdf/06m0f4gg2pywxw.pdf",
  "summary": "### Summary of Material Information:  \n**Announcement Type: Strategic Partnership**  \n\n- **Partnership** with **Tecan** (automation solutions) and **Repado** (IVD software) to develop **fully automated, scalable infectious disease testing solutions**.  \n- **Key features**:  \n  - Integration of **Tecan\u2019s liquid handling automation**, **Repado\u2019s regulatory-compliant software**, and **GSS\u2019s assay portfolio** (Respiratory, GI, STI panels).  \n  - Focus on **IVDR/FDA compliance**, reduced manual workflow, and scalability for labs.  \n- **Commercial impact**:  \n  - Early access planned for **select global reference labs**; potential to enhance **GSS\u2019s market reach/testing efficiency**.  \n  - Plans to expand **3base\u00ae technology menu** alongside the new platform.  \n\n**No capital/financial terms disclosed**; partnership implies long-term growth strategy.  \n\n*Omitted: Leadership quotes, background on companies, routine operational details.*",
  "usage": {
    "prompt_tokens": 1243,
    "completion_tokens": 213,
    "total_tokens": 1456,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-21T22:51:30.997524"
}